Karolinska is looking for AI innovation partners


Karolinska is looking for both innovation partners and solutions regarding AI decision support tools for automatic detection and classification of solid and semi-solid lung nodules in computed tomography (CT) and the integrated diagnostic processes.

Are you interested?

For more information, please go to the Region Stockholm tender web site

Or contact Tomas Borgegård: tomas.borgegard@sll.se
Innovation Manager at the Center for Innovation at Karolinska University Hospital

Eventually, a general lung cancer screening will be introduced that will be dependent on AI system support.

Karolinska now invites companies to take part in a Request for Information, RFI. The purpose is to obtain a better understanding of the state of art with regard to AI decision support products in the area of lung CT, and the interest and capability of the market to both supply ready available CE-marked AI-tools as well as potentially entering into a partnership with Karolinska for the further development of functionalities not yet available on the market.

The RFI will be followed by dialogues with selected companies after which Karolinska will decide on a strategy going forward, possibly involving the establishment of procurement documents for selection, competition, and business agreement, ultimately leading to a rewarding collaboration for both parties with a sustainable result.

About Karolinska

Karolinska University Hospital is a leading Scandinavian premier health facility and one of Europe's largest hospitals. Karolinska has the primary responsibility to deliver highly specialized care and to develop future healthcare in Region Stockholm, and also to offer highly specialized care to international patients.

Karolinska is also a founding member of the European University Hospital Alliance, EUHA, formed in 2017 to foster excellence on research, healthcare, education and innovation for improving care value at a European level.

The Karolinska radiology department has about 200 radiologists and 20 CT scanners. The annual number of CT examinations are about 100,000, most of which contain thorax, and all contain parts of the skeleton. Karolinska are now about to start a pilot project for screening for lung cancer, where 1000 patients per year for two years, will be examined for later evaluation. Eventually, a general lung cancer screening will be introduced that will be dependent on AI system support. When the entire screening program is rolled out the annual number of CTs is estimated to be approximately 10,000 for the Stockholm Region. 

  • This innovation work further builds on knowledge generated from the now completed I-AID project

About the Center for Innovation